Trial · NCT01166139
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Prolonged QTC | Cardiac disorders | Nilotinib 400 mg Twice Daily | 6 | 7 | 9 |
| other | Increased AST | Investigations | Nilotinib 400 mg Twice Daily | 5 | 7 | 6 |
| other | Elevated Total Bilirubin | Investigations | Nilotinib 400 mg Twice Daily | 5 | 7 | 6 |
| other | Increased ALT | Investigations | Nilotinib 400 mg Twice Daily | 4 | 7 | 5 |
| other | Anemia | Blood and lymphatic system disorders | Nilotinib 400 mg Twice Daily | 3 | 7 | 3 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Nilotinib 400 mg Twice Daily | 3 | 7 | 3 |
| other | Headache | Nervous system disorders | Nilotinib 400 mg Twice Daily | 3 | 7 | 3 |
| other | Nausea | Ear and labyrinth disorders | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Reflux | Gastrointestinal disorders | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Elevated ESR | Blood and lymphatic system disorders | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Increased Lipase | Investigations | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Increased Amylase | Investigations | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | Nilotinib 400 mg Twice Daily | 2 | 7 | 2 |
| other | Vomiting | Metabolism and nutrition disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 2 |
| other | Decreased White Blood Cell Count | Blood and lymphatic system disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
| other | Increased White Blood Cell Count | Blood and lymphatic system disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
| other | Coronary Artery Disease | Cardiac disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
| other | Syncope | Nervous system disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
| other | Hospitalization for CABG | Cardiac disorders | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
| other | Allergic Rhinitis | Infections and infestations | Nilotinib 400 mg Twice Daily | 1 | 7 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01166139/events